<DrugInformationSummary id="CDR0000767283"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>The HPV nonavalent vaccine protects against infection with low-risk HPV types 6 and 11, which cause most genital warts, and against high-risk HPV types 16, 18, 31, 33, 45, 52, and 58, which cause several types of precancers and cancer.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-HPV-nonavalent-vaccine">Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000767261">recombinant human papillomavirus nonavalent vaccine</TerminologyLink><GlossaryLink ref="CDR0000767620">recombinant human papillomavirus nonavalent vaccine</GlossaryLink><USBrandNames><USBrandName>Gardasil 9</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus NOH-nuh-VAY-lent vak-SEEN</TermPronunciation><MediaLink ref="CDR0000769331" type="audio/mpeg" alt="" language="en" id="_4"/><MediaLink ref="CDR0000769330" type="audio/mpeg" alt="" language="es" id="_5"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a21f4f4b-b891-4f25-b747-cb9ec7d865d6&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a21f4f4b-b891-4f25-b747-cb9ec7d865d6&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_4"><Title>Use in Cancer</Title>                                                              
                            
  <Para id="_6">The HPV nonavalent vaccine is used in individuals aged 9 to 45 years to prevent:</Para><ItemizedList Style="bullet" id="_3"><ListItem><Strong><GlossaryTermRef href="CDR0000444966" dictionary="Cancer.gov" audience="Patient">Anal cancer</GlossaryTermRef>.</Strong></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000444973" dictionary="Cancer.gov" audience="Patient">Cervical cancer</GlossaryTermRef>.</Strong></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000257519" dictionary="Cancer.gov" audience="Patient">Head and neck cancer</GlossaryTermRef></Strong>, including <GlossaryTermRef href="CDR0000446523" dictionary="Cancer.gov" audience="Patient">oropharyngeal cancer</GlossaryTermRef>.¹</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000523460" dictionary="Cancer.gov" audience="Patient">Vaginal cancer</GlossaryTermRef>.</Strong></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044776" dictionary="Cancer.gov" audience="Patient">Vulvar cancer</GlossaryTermRef>.</Strong></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">Lesions</GlossaryTermRef></Strong> that sometimes lead to anal, cervical, vaginal, or vulvar cancer.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000409765" dictionary="Cancer.gov" audience="Patient">Genital warts</GlossaryTermRef>.</Strong></ListItem></ItemizedList>
  
 <Para id="_7">¹This use is approved under FDA’s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that recombinant human papillomavirus (HPV) nonavalent vaccine provides a clinical benefit in these patients.</Para></Section><Section id="_About"><Title>More About Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767261">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.81">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a615028.html">Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.82"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.83">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/cervical-cancer-hpv-vaccine-one-dose-kenya">More Evidence that One HPV Vaccine Dose Protects against Cancer-Causing Infections</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer">HPV and Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2021/hpv-vaccine-parents-safety-concerns">Despite Proven Safety of HPV Vaccines, More Parents Have Concerns</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet">Human Papillomavirus (HPV) Vaccines</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2020/hpv-vaccine-single-dose-long-term-protection">Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2019/men-oral-hpv-infection-vaccine-herd-immunity">HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2018/hpv-vaccine-presidents-cancer-panel-improving-uptake">The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C119664">Find Clinical Trials for Recombinant Human Papillomavirus Nonavalent Vaccine</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2014-12-29</DateFirstPublished><DateLastModified>2023-03-10</DateLastModified></DrugInformationSummary>
